1984 | Inception of Ink business
Started printing ink operations as a partnership firm
1991 - 1992 | Entry into agrochemical business
- Incorporation of Hindustan Inks & Resins Ltd (HIRL)
- Started Mitsu Industries Ltd (Mitsu) at Vapi as an agrochemical intermediates unit
1995
A market leader in
Ink Industry
- HIRL emerges as a market leader in India
- Mitsu becomes the largest pyrethroid class of insecticide in India
2000 - 2001 Micro inks spread across the world
- HIRL implements integrated single stream with backward integration
- Positioned as the 3rd company in the world to produce alkali blue
- HIRL launches Micro Inks Crop. USA, A wholly owned subsidiary
- International revenues exceed 59% spread over 70 countries
2004 | Expands Global Reach
- 15th largest ink company in the world
2005 | Merge with Huber Group
- Becomes 4th largest globally with the Huber group merger
- Maa foundation incorporated as a nonprofit Organization
2006 - 2008 Entry into the Healthcare & Education sectors
- M3 Investment Pvt. Ltd incorporated for pursuing long term value investing model
- Acquired International Technologies Pvt.Ltd, a company engaged in distribution of medical devices
- Enters into a global partnership for knee implants with Maxx Orthopedics Inc
- Mexus Education Pvt. Ltd incorporated
2009 | Set up of Meril
Meril Life Science Pvt. Ltd starts setting up a plant for manufacturing of stents
2009 | Set up of Meril
Meril Life Science Pvt. Ltd starts setting up a plant for manufacturing of stents
2012 | Diversification into Healthcare sector
Set up of Meril Diagnostics, Meril Healthcare, Meril Endo-surgery
2012 | Diversification into Healthcare sector
Set up of Meril Diagnostics, Meril Healthcare, Meril Endo-surgery
2013 | A renowned name in
health across the globe
Meril exports to more than 70 countries
2016 - 17 | Established Meril Academy
World class state-of-the-art training facility for medical professionals
2020 | Leading manufacturer of healthcare devices
Meril becomes the 2nd largest player with a market share of 20% for stents in India
Present
Conducting business in more than 100 countries